Parallel Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.2K | Buy |
798
+194
| +32% | +$17.8K | ﹤0.01% | 1773 |
|
|
2025
Q4 | $54.3K | Sell |
604
-291
| -33% | -$27.6K | ﹤0.01% | 1804 |
|
|
2025
Q3 | $88.2K | Buy |
895
+271
| +43% | +$26.9K | ﹤0.01% | 1483 |
|
|
2025
Q2 | $56.9K | Sell |
624
-468
| -43% | -$45.3K | ﹤0.01% | 1647 |
|
|
2025
Q1 | $124K | Sell |
1,092
-38
| -3% | -$4.07K | ﹤0.01% | 1188 |
|
|
2024
Q4 | $119K | Sell |
1,130
-76
| -6% | -$8.15K | ﹤0.01% | 1177 |
|
|
2024
Q3 | $130K | Buy |
1,206
+337
| +39% | +$36.8K | ﹤0.01% | 1141 |
|
|
2024
Q2 | $94.3K | Sell |
869
-56
| -6% | -$6.6K | ﹤0.01% | 1215 |
|
|
2024
Q1 | $122K | Buy |
925
+56
| +6% | +$7K | ﹤0.01% | 1085 |
|
|
2023
Q4 | $106K | Sell |
869
-75
| -8% | -$8.37K | ﹤0.01% | 1095 |
|
|
2023
Q3 | $106K | Sell |
944
-639
| -40% | -$81.1K | ﹤0.01% | 1058 |
|
|
2023
Q2 | $231K | Buy |
1,583
+85
| +6% | +$11.6K | 0.01% | 726 |
|
|
2023
Q1 | $194K | Buy |
1,498
+867
| +137% | +$109K | 0.01% | 783 |
|
|
2022
Q4 | $80.5K | Sell |
631
-85
| -12% | -$9.86K | ﹤0.01% | 1078 |
|
|
2022
Q3 | $75K | Buy |
716
+66
| +10% | +$7.24K | ﹤0.01% | 1088 |
|
|
2022
Q2 | $68K | Sell |
650
-256
| -28% | -$30.4K | ﹤0.01% | 1117 |
|
|
2022
Q1 | $117K | Sell |
906
-125
| -12% | -$15.1K | ﹤0.01% | 935 |
|
|
2021
Q4 | $127K | Buy |
1,031
+311
| +43% | +$40.7K | ﹤0.01% | 919 |
|
|
2021
Q3 | $102K | Buy |
720
+64
| +10% | +$9.41K | ﹤0.01% | 974 |
|
|
2021
Q2 | $102K | Buy |
656
+93
| +17% | +$15.1K | ﹤0.01% | 948 |
|
|
2021
Q1 | $88K | Buy |
563
+97
| +21% | +$15K | ﹤0.01% | 938 |
|
|
2020
Q4 | $70K | Sell |
466
-47
| -9% | -$6.64K | ﹤0.01% | 956 |
|
|
2020
Q3 | $68K | Buy |
513
+2
| +0.4% | +$261 | ﹤0.01% | 935 |
|
|
2020
Q2 | $59K | Sell |
511
-73
| -13% | -$8.41K | ﹤0.01% | 986 |
|
|
2020
Q1 | $57K | Sell |
584
-280
| -32% | -$36.7K | ﹤0.01% | 888 |
|
|
2019
Q4 | $126K | Sell |
864
-98
| -10% | -$13.5K | 0.01% | 685 |
|
|
2019
Q3 | $128K | Buy |
962
+173
| +22% | +$22.3K | 0.01% | 638 |
|
|
2019
Q2 | $90K | Buy |
789
+141
| +22% | +$16.5K | 0.01% | 692 |
|
|
2019
Q1 | $80K | Sell |
648
-98
| -13% | -$11.1K | 0.01% | 689 |
|
|
2018
Q4 | $75K | Sell |
746
-357
| -32% | -$40.1K | 0.01% | 626 |
|
|
2018
Q3 | $141K | Hold |
1,103
| – | – | 0.02% | 503 |
|
|
2018
Q2 | $119K | Buy |
1,103
+65
| +6% | +$7.07K | 0.02% | 493 |
|
|
2018
Q1 | $110K | Sell |
1,038
-99
| -9% | -$11.5K | 0.02% | 474 |
|
|
2017
Q4 | $133K | Buy |
1,137
+32
| +3% | +$3.62K | 0.02% | 407 |
|
|
2017
Q3 | $119K | Buy |
1,105
+27
| +3% | +$3.12K | 0.02% | 433 |
|
|
2017
Q2 | $127K | Sell |
1,078
-114
| -10% | -$13.5K | 0.02% | 413 |
|
|
2017
Q1 | $138K | Buy |
1,192
+205
| +21% | +$23.2K | 0.03% | 368 |
|
|
2016
Q4 | $99K | Buy |
+987
| New | +$106K | 0.02% | 392 |
|
Other funds holding ZBH
VCM
VPM
Parallel Advisors's ZBH Position: Q1 2026 in Review
Parallel Advisors increased its Zimmer Biomet (ZBH) stake by 32% in Q1 2026, buying an estimated $17.8K and bringing the position to 798 shares worth $72.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.
Parallel Advisors first reported a position in ZBH in Q4 2016 and has held it in 38 quarters since. The position peaked at $231K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Parallel Advisors held 798 shares of Zimmer Biomet worth $72.2K as of Q1 2026.
- Parallel Advisors bought 194 Zimmer Biomet shares in Q1 2026, an estimated $17.8K.
- Zimmer Biomet made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1773 holding.
- Parallel Advisors first reported a position in Zimmer Biomet in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Zimmer Biomet position peaked at $231K in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.